Goldfinch Bio Company
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
Technology:
COVID, Organoids
Industry:
Preventive Tech, Providers
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
N/A
Total Funding:
210000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership